Biomind Labs (NEOE:BMND) Long-Term Debt : C$0.00 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Long-Term Debt?

Biomind Labs's Long-Term Debt for the quarter that ended in Sep. 2023 was C$0.00 Mil.

Biomind Labs Long-Term Debt Historical Data

The historical data trend for Biomind Labs's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Long-Term Debt Chart

Biomind Labs Annual Data

Trend

Dec21

Dec22

Long-Term Debt

Biomind Labs Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Long-Term Debt	Get a 7-Day Free Trial						-	-	-	-	-

Biomind Labs (NEOE:BMND) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Biomind Labs Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Biomind Labs's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomind Labs (NEOE:BMND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (NEOE:BMND) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

3XI:Germany

Address

Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000

Website

https://www.biomindlabs.com

Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs (NEOE:BMND) Headlines

No Headlines